Jeffrey Lipman

41.9k citations

594 papers · 26.1k indexed · 6 hit papers · h-index 82

Impact in

Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 105
- Antibiotic Use and Resistance 105
Molecular Medicine 121
- Antibiotic Resistance in Bacteria 121

Co-authors: Jason A. Roberts Andrew Udy David L. Paterson Steven C. Wallis Robert Boots Rinaldo Bellomo Michael S. Roberts John Myburgh
Journals: International Journal of Antimicrobial Agents (54 papers)Anaesthesia and Intensive Care (42 papers)Antimicrobial Agents and Chemotherapy (42 papers)Journal of Antimicrobial Chemotherapy (37 papers)Intensive Care Medicine (31 papers)
Partner nations: Australia France South Africa

In The Last Decade

Jeffrey Lipman

574 papers receiving 25.5k citations

Hit Papers

6 papers align trajectories log scale

Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit 2018 · 306 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Open Forum Infectious Diseases
2014 The Lancet Respiratory Medicine
2014 The Lancet Infectious Diseases
2014 Advanced Drug Delivery Reviews
2012 New England Journal of Medicine
2009 Critical Care Medicine

Peers

Countries citing papers authored by Jeffrey Lipman

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Lipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lipman more than expected).

Fields of papers citing papers by Jeffrey Lipman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lipman. The network helps show where Jeffrey Lipman may publish in the future.

Co-authors

The 25 scholars most cited alongside Jeffrey Lipman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey Lipman Line = papers co-authored together Jeffrey Lipman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intensive Care Unit activity in France from the national database between 2013 and 2019: More critically ill patients, shorter stay and lower mortality rate Anaesthesia Critical Care & Pain Medicine ·Nicolas Boulet, Amal Boussere, M. Mezzarobba, Mircea T. Sofonea, Didier Payen, Jeffrey Lipman, Kevin B. Laupland, Jordi Rello, Jean‐Yves Lefrant, Laurent Müller, Claire Roger, Romain Pirracchio, Thibault Mura, Thierry Boudemaghe	2023	3
2	Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates Journal of Antimicrobial Chemotherapy ·Chandra Datta Sumi, Aaron J. Heffernan, Saiyuri Naicker, Kyra Cottrell, Steven C. Wallis, Jeffrey Lipman, Patrick N. A. Harris, Fekade B. Sime, Jason A. Roberts	2022	3
3	Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care Microbial Genomics ·Leah W. Roberts, Brian M. Forde, Trish Hurst, Weiping Ling, Graeme R. Nimmo, Haakon Bergh, Narelle George, Krispin Hajkowicz, John F. McNamara, Jeffrey Lipman, Budi Permana, Mark A. Schembri, David L. Paterson, Scott A. Beatson, Patrick N. A. Harris	2021	31
4	Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic Study Antibiotics ·Francisco Beraldi‐Magalhães, Suzanne L. Parker, Cristina Sanches, Leandro Sousa Garcia, Brenda Karoline Souza Carvalho, Mariana Millan Fachi, Marcus Vinícius de Liz, Roberto Pontarolo, Jeffrey Lipman, Marcelo Cordeiro‐Santos, Jason A. Roberts	2021	3
5	Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime Clinical Pharmacokinetics ·Jiajun Liu, Michael Neely, Jeffrey Lipman, Fekade B. Sime, Jason A. Roberts, Patrick J. Kiel, Sean N. Avedissian, Nathaniel J. Rhodes, Marc H. Scheetz	2020	9
6	A Multicenter Trial of Vena Cava Filters in Severely Injured Patients New England Journal of Medicine ·Kwok M. Ho, Sudhakar Rao, Stephen Honeybul, René Zellweger, Bradley Wibrow, Jeffrey Lipman, Anthony Holley, Alan Kop, Elizabeth Geelhoed, Tomás Corcoran, Philip Misur, Cyrus Edibam, Ross Baker, Jenny Chamberlain, Claire Forsdyke, Frederick B. Rogers	2019	88
7	Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion International Journal of Antimicrobial Agents ·Sofie Dhaese, Pieter Colin, Hermann Willems, Aaron J. Heffernan, Bram Gadeyne, Sarah Van Vooren, Pieter Depuydt, Eric A. J. Hoste, Veronique Stove, Alain Verstraete, Jeffrey Lipman, Jason A. Roberts, Jan J. De Waele	2019	14
8	Defining optimal dosing of ciprofloxacin in patients with septic shock Journal of Antimicrobial Chemotherapy ·Jason A. Roberts, Abdulaziz S. Alobaid, Steven C. Wallis, Anders Perner, Jeffrey Lipman, Fredrik Sjövall	2019	19
9	Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review International Journal of Antimicrobial Agents ·Aaron J. Heffernan, Fekade B. Sime, Jeffrey Lipman, Jayesh Dhanani, Katherine T. Andrews, David Ellwood, Keith Grimwood, Jason A. Roberts	2018	46
10	Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit Open Forum Infectious Diseases ·Yasser Sakr, Ulrich Jaschinski, Xavier Wittebole, Tamás Szakmány, Jeffrey Lipman, Silvio A. Ñamendys‐Silva, Ignacio Martín‐Loeches, Marc Léone, Mary‐Nicoleta Lupu, Jean‐Louis Vincent, (unknown) Hit paper breakdown →	2018	306
11	Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam Antimicrobial Agents and Chemotherapy ·Fekade B. Sime, Saurabh Pandey, Nermin Karamujic, Suzanne L. Parker, Elizabeth Alexander, Jeffery S. Loutit, Stephanie Durso, David C. Griffith, Jeffrey Lipman, Steven C. Wallis, Jason A. Roberts	2018	27
12	Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients International Journal of Antimicrobial Agents ·Claire Roger, Menino Osbert Cotta, Laurent Müller, Steven C. Wallis, Jeffrey Lipman, Jean‐Yves Lefrant, Jason A. Roberts	2017	20
13	Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review International Journal of Antimicrobial Agents ·Abdulaziz S. Alobaid, Maya Hites, Jeffrey Lipman, Fabio Silvio Taccone, Jason A. Roberts	2016	90
14	A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study Critical Care and Resuscitation ·Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis, S. A. R. Webb, Rinaldo Bellomo, Charles D. Gomersall, Charudatt Shirwadkar, Glenn M. Eastwood, John Myburgh, David L. Paterson, Therese Starr, Andrew Udy, Sanjoy K. Paul, Jeffrey Lipman	2013	15
15	End points for Phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting Critical Care and Resuscitation ·Paul J. Young, Carol Hodgson, Joel M. Dulhunty, Manoj Saxena, Michael Bailey, Rinaldo Bellomo, Andrew Davies, Simon Finfer, Peter Krüger, Jeffrey Lipman, John Myburgh, Sandra Peake, Ian Seppelt, Stephen Streat, Rhiannon Tate, S. A. R. Webb	2012	44
16	Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime Critical Care and Resuscitation ·Nicholas Smith, Ross Freebairn, Michael A J Park, Steven C. Wallis, Jason A. Roberts, Jeffrey Lipman	2012	36
17	A new paradigm for treating infections: “go hard and go home” Critical Care and Resuscitation ·Jeffrey Lipman, Robert Boots	2009	17
18	The implications of enterococci for the intensive care unit Critical Care and Resuscitation ·Indranil Chatterjee, Jonathan R. Iredell, Marion L. Woods, Jeffrey Lipman	2007	21
19	A randomised controlled study of the effecacy of hypromellose and lacri-Lube combination versus polyethylene/clingwrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient eCite Digital Repository (University of Tasmania) ·Natasha Koroloff, Robert Boots, Jeffrey Lipman, Peter Thomas, Claire M. Rickard, Fiona Coyer	2004	65
20	Towards Better ICU Antibiotic Dosing Critical Care and Resuscitation ·Jeffrey Lipman	2000	3

About Jeffrey Lipman

Jeffrey Lipman is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Critical Care and Intensive Care Medicine and Nephrology, having authored 594 papers that have together received 26.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (321 papers), Antibiotic Resistance in Bacteria (121 papers), Sepsis Diagnosis and Treatment (106 papers), Antibiotic Use and Resistance (105 papers), Pneumonia and Respiratory Infections (101 papers), Bacterial Identification and Susceptibility Testing (60 papers), Antimicrobial Resistance in Staphylococcus (44 papers) and Acute Kidney Injury Research (44 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (4.6k citations), Molecular Medicine (5.8k citations), Pharmacology (14.2k citations), Critical Care and Intensive Care Medicine (3.3k citations) and Clinical Biochemistry (2.9k citations). Jeffrey Lipman has collaborated with scholars based in Australia, France and South Africa. Frequent co-authors include Jason A. Roberts, Andrew Udy, David L. Paterson, Steven C. Wallis, Robert Boots, Rinaldo Bellomo, Michael S. Roberts, John Myburgh, Jacobus Ungerer and Brett McWhinney. Their work appears in journals such as International Journal of Antimicrobial Agents, Anaesthesia and Intensive Care, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Intensive Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact